1471-0528/asset/BJO_left.gif?v=1&s=0fb87361cdb6be25fdf05019eed6d47f5143f610)
1471-0528/asset/olbannerright.gif?v=1&s=3892ef16ff18d6834c302faf85268a49f5fc588f)
Changes in circulating alphafetoprotein following administration of mifepristone in first trimester pregnancy
Article first published online: 19 AUG 2005
DOI: 10.1111/j.1471-0528.1990.tb02477.x
Issue
1471-0528/asset/cover.gif?v=1&s=b4e1d96c46e18c61210d584b63c13ee375cf562b "BJOG: An International Journal of Obstetrics & Gynaecology")
BJOG: An International Journal of Obstetrics & Gynaecology
Volume 97, Issue 11, pages 1030–1032, November 1990
Additional Information
How to Cite
CHARD, T., OLAJIDE, F. and KITAU, M. (1990), Changes in circulating alphafetoprotein following administration of mifepristone in first trimester pregnancy. BJOG: An International Journal of Obstetrics & Gynaecology, 97: 1030–1032. doi: 10.1111/j.1471-0528.1990.tb02477.x
Publication History
- Issue published online: 19 AUG 2005
- Article first published online: 19 AUG 2005
- Received 27 Februarv 1990 Accepted 20 May 1990
- Abstract
- References
- Cited By
Summary. The occurrence of fetomaternal haemorrhage was investigated in 30 women by measuring maternal serum alphafetoprotein (AFP) levels before and after the administration of mifepristone (RU 486) for termination of first trimester pregnancy. A significant rise in AFP levels was seen in 21 women (70%), the increase ranging from 6 to 660% of baseline levels. The apparent frequency of fetomaternal haemorrhage was similar to that reported previously for surgical termination of first trimester pregnancies.